Skip to content

Effect Of Ayurvedic Medicine In Dushta Vrana (Infected Wound)

An Open Randomized Controlled Clinical Trial Of Tiladi Lepa In Management Of Dushta Vrana With Special Reference To Infected Wound - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/03/105621
Enrollment
68
Registered
2026-03-09
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue

Interventions

None listed

Sponsors

Dr Vivekanand Shivanand Deshmukhe
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient Age Group Of 18 to 60 Years 2 All Patients Irrespective Of Gender Occupation Are Taken 3 Patient Having Sign And Symptoms Of Dushta Vrana For 1 To 2 Weeks Having Area Upto Length 5cm Into Breadth 5cm Into Depth 5mm And Restricted To Localized Area Will Be Randomly Selected

Exclusion criteria

Exclusion criteria: 1 The Patient Who Has Underlying Bony Lesions 2 Patients With Malignant Ulcer Tuberculous Ulcer Lepromatous Ulcer Gangrenous Wound Bleeding Disorders 3 HIV HbSAg Positive Patients 4 Diabetic Wound Will Not Be Selected

Design outcomes

Primary

MeasureTime frame
Tiladi lepa is effective in management of Dushta VranaTimepoint: 11 Days

Secondary

MeasureTime frame
Metrogyl p 2% ointment is effective in management of Dushta VranaTimepoint: 11 Days

Countries

India

Contacts

Public ContactDr Sunil Jadhav

Hon Shri Annasaheb Dange Ayurved Medical College Post Graduate And Research Center Ashta Tal Walwa Dist Sangli 416301

sjadhav21066@gmail.com9823279290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026